Viral Vector Manufacturing Market Research Report: by Type (Retroviral Vectors, Adenoviral Vectors and others), by Disease (Genetic Disorders, Infectious Diseases, and others), by Application (Gene Therapy, Vaccinology), by End User — Forecast till 2027
viral vector manufacturing market is expected to grow significantly over the forecast period. It is projected that the global viral vector manufacturing market is expected to register a CAGR Approx. 22.65% with an expected market value of USD 319 million during the forecast period of 2018–2023
Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6890
Competitive Analysis:
- Kaneka Eurogentec SA
- REGENXBIO Inc
- Cobra Biologics
- Cell and Gene Therapy Catapult
- Brammer Bio
- FinVector Vision Therapies
- uniQure NV
- Spark Therapeutics Inc
- Oxford BioMedica
- General Electric Company
- Merck KGaA
- Lonza
Segmentation:
- The global viral vector manufacturing market is segmented on the basis of type, disease, application, end use, and region.
- By type, the global viral vector manufacturing market is segmented into retroviral vectors, adenoviral vectors, adeno-associated viral vectors, and other viral vectors. The retroviral vectors segment is further sub-segmented into lentiviral vectors and gamma-retroviral vectors. The retroviral vectors segment holds the largest share in the global viral vector manufacturing market. Retroviruses contain the enzyme reverse transcriptase, which enables easy assimilation into the host DNA. This has driven the demand for retroviral vectors. The adenoviral vectors segment is also expected to exhibit rapid growth over the forecast period.
- By disease, the global viral vector manufacturing market is segmented into cancer, genetic disorders, infectious diseases, and others.
- By application, the market is segmented into gene therapy and vaccinology.
- By end use, the global viral vector manufacturing market is segmented into pharma and biotech companies, research institutes, and others.
Regional Analysis:
The North American Region heading with the growing prevalence of autoimmune and chronic diseases, accounts for the leading market for viral vector manufacturing, globally. Moreover, technological advancements in the manufacturing of these vectors is a key force driving the growth of this market.
Additionally, favorable reimbursement policies and the presence of well-developed healthcare infrastructure, and increasing geriatric population are some of the key driving forces contributing to the growth of the regional market.
read more @ https://www.marketresearchfuture.com/reports/viral-vector-manufacturing-market-6890
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
+1 646 845 9312
